News
Pfizer CEO Albert Bourla is expected at a pro-Trump fundraiser on Friday, sources told CBS News, one day after the president ...
As investors and industry watchers juggle the twin possibilities of pharmaceutical import tariffs and potential drug pricing ...
Pfizer ( PFE) CEO Albert Bourla said Tuesday he has a "special relationship" with President Trump, cemented during the ...
CEO says pharma executives discussed Trump's call to launch DTC initiatives under his Most Favored Nation policy to lower U.S ...
Pfizer ( PFE) shares gained on Tuesday after the New York-based pharma giant reported better-than-expected financials for Q2 2025 and increased its full-year earnings outlook, citing, among other ...
4don MSN
Pfizer CEO says drugmakers ‘are all ready to roll up their sleeves and execute’ as president demands more direct-to-consumer ...
George Tidmarsh takes over temporarily at CBER following Vinay Prasad’s abrupt departure; Replimmune trial leaders protest ...
8h
TipRanks on MSNTrump Considers Cannabis Reclassification That Could Boost $45 Billion U.S. MarketPresident Donald Trump is weighing whether to reclassify cannabis as a less dangerous drug. People familiar with the matter ...
When President Donald Trump hits "post" on Truth Social, Wall Street braces for impact. What Happened: Various stock prices — ...
Pfizer's Albert Bourla told investors that major drugmakers are "ready to roll up their sleeves" and build out more direct-to ...
Pfizer said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results